                         SEQUENCE LISTING

<110>  Novartis Forschungsstiftung, Zweigniederlassung Friedrich 
       Miescher Institute for Biomedical Research
 
<120>  Modulating XRN1

<130>  PAT054160

<160>  11    

<170>  PatentIn version 3.3

<210>  1
<211>  20
<212>  DNA
<213>  Caenorhabditis elegans

<400>  1
ccgctggttg ttaaggatgt                                                 20


<210>  2
<211>  20
<212>  DNA
<213>  Caenorhabditis elegans

<400>  2
ctccattttc ttgcggagag                                                 20


<210>  3
<211>  31
<212>  DNA
<213>  Caenorhabditis elegans

<400>  3
gaaagatcta tgggtgtccc caagttctac c                                    31


<210>  4
<211>  34
<212>  DNA
<213>  Caenorhabditis elegans

<400>  4
gaactgcagt taagatgaag ccgtcggatt gctg                                 34


<210>  5
<211>  22
<212>  DNA
<213>  Caenorhabditis elegans

<400>  5
aactatacaa cctactacct ca                                              22


<210>  6
<211>  27
<212>  DNA
<213>  Caenorhabditis elegans

<400>  6
gcttggaagg catccatgct gaccatt                                         27


<210>  7
<211>  21
<212>  DNA
<213>  Caenorhabditis elegans

<400>  7
tcatttctcg cacctacctc a                                               21


<210>  8
<211>  20
<212>  DNA
<213>  Caenorhabditis elegans

<400>  8
ccgctggttg ttaaggatgt                                                 20


<210>  9
<211>  20
<212>  DNA
<213>  Caenorhabditis elegans

<400>  9
ctccattttc ttgcggagag                                                 20


<210>  10
<211>  31
<212>  DNA
<213>  Caenorhabditis elegans

<400>  10
gaaagatcta tgggtgtccc caagttctac c                                    31


<210>  11
<211>  34
<212>  DNA
<213>  Caenorhabditis elegans

<400>  11
gaactgcagt taagatgaag ccgtcggatt gctg                                 34


